文献速递其他结缔组织病

系统性硬化症患者胃肠道传输、Medsger胃肠道严重程度与UCLA GIT 2.0症状的关系

Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-01-25

该研究纳入71例有胃肠道症状的系统性硬化症(SSc)患者和18例健康对照,采用全肠道传输闪烁显像评估从食管到结肠的传输。结果显示88%患者存在至少一个肠道区域传输异常,需要全肠外营养的患者均存在小肠传输延迟,Medsger胃肠道评分3分者更易出现严重结肠传输延迟,且传输延迟部分解释了肠道症状和Medsger胃肠道严重程度。

要点

  • 88%有胃肠道症状的SSc患者全肠道传输显像显示至少一个区域异常。
  • 需要全肠外营养的患者均存在小肠传输延迟,其他Medsger组仅约11%。

核心结论

  • SSc肠道疾病影响胃肠道内容物传输,传输延迟部分解释了肠道症状和Medsger胃肠道严重程度。
  • 需要前瞻性研究评估针对高风险的严重胃肠道并发症患者早期干预胃肠道传输异常是否有益。

研究设计与样本

  • 研究纳入71例有胃肠道症状的SSc患者和18例健康对照,均接受全肠道传输闪烁显像评估食管至结肠传输。
  • 测量各胃肠道区域传输延迟的存在和排空百分比,比较不同Medsger胃肠道严重程度评分(0-4分)类别间及UCLA GIT 2.0各领域和总分(0-3分)间的传输测量。

主要发现

  • 88%的患者在全肠道传输闪烁显像中显示超过一个肠道区域异常。
  • 需要全肠外营养的所有患者均有小肠传输延迟,而其他Medsger胃肠道严重程度组仅约11%有延迟(P ≤ 0.01)。
  • 胃食管反流病症状与食管传输延迟(r = -0.31,P = 0.05)和胃排空延迟(r = -0.32,P = 0.05)存在 modest 关联。

临床怎么用

  • 对SSc合并胃肠道症状患者,可考虑全肠道传输闪烁显像评估传输异常,尤其需全肠外营养或Medsger评分3分者。
  • 识别小肠或结肠传输延迟有助于解释胃肠道症状和Medsger胃肠道严重程度,可能指导早期治疗干预。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic sclerosis (SSc)-associated gastrointestinal (GI) complications are attributed to a variety of factors, including diet, microbiota dysbiosis, or GI transit abnormalities. Our objective was to examine the contribution of abnormal GI transit to SSc Medsger GI severity scores and/or University of California Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA GIT) 2.0 symptoms. METHODS: Patients with SSc and GI symptoms (n = 71) and healthy controls (n = 18) underwent whole gut transit (WGT) scintigraphy to assess transit from the esophagus to the colon. The presence of delayed transit and percent emptying in each GI region were measured. We compared the WGT measurements between categories of the Medsger GI severity score (0-4) and across UCLA GIT 2.0 domains and total score (0-3). RESULTS: A total of 88% of patients had >1 abnormal region of the gut on WGT scintigraphy. All patients requiring total parenteral nutrition had delayed small bowel transit, compared to only approximately 11% of patients in other Medsger GI severity groups (P ≤ 0.01). Severe colonic transit delays were more likely in patients with Medsger GI scores of 3 (pseudo-obstruction and/or malabsorption) compared to other Medsger GI groups (P = 0.02). Seventy-percent of these patients had ≤30% colonic emptying at 72 hours. Modest associations were noted between gastroesophageal reflux disease symptoms and delayed esophageal (r = -0.31, P = 0.05) and gastric emptying (r = -0.32, P = 0.05). CONCLUSION: These data are important in providing evidence that SSc bowel disease affects transit of GI content and that delay in transit accounts in part for both bowel symptoms and Medsger GI severity. Prospective studies examining the benefit of early therapeutic intervention targeting GI transit abnormalities in patients at high risk for severe GI complications are needed.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. McMahan ZH, Tucker AE, Perin J, et al. Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022. PMID: 33064934. doi:10.1002/acr.24488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。